文档详情

谷参肠安合痛泻要方治疗腹泻型肠易激综合征例疗效观察.doc

发布:2018-05-29约4.45千字共10页下载文档
文本预览下载声明
谷参肠安合痛泻要方治疗腹泻型肠易激综合征49例疗效观察 nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; 作者:陈飞雁, 崔麦茂, 梁德芬nbsp; 【关键词】nbsp; 腹泻;,,结肠疾病,功能性;,,谷参肠安   摘要:目的:观察谷参肠安合痛泻要方治疗腹泻型肠易激综合征(IBS)的临床疗效。方法:将98例患者随机分为两组。治疗组49例,以谷参肠安合痛泻要方(炒白术、白芍、陈皮、防风)治疗;对照组49例,以单纯谷参肠安治疗。两组疗程均为4周。结果:治疗组总有效率为87.8%,对照组为65.3%,两组比较有统计学意义(P<0.05),治疗前后两组主要症状均有明显改善,差异有非常显著意义(P<0.01),治疗组与对照组治疗后比较,差异亦有统计学意义(P<0.05)。结论:谷参肠安合痛泻要方治疗腹泻型肠易激综合征有较好的临床疗效。   关键词:nbsp; 腹泻;nbsp; 结肠疾病,功能性;nbsp; 谷参肠安   The Efficiency Observation of Gushen Changan plus Tongxie Yaofang on 49 Casesnbsp; Irriable Bowel Syndrome of Diarrhea type   Abstract: Objective: To observe the clinical effect of gushen changan and tongxie yaofang onnbsp; irritable bowel syndrome.Method: Divided 98 patients randomly into two groups. Group one is treated with gushen changan and tongxie yaofang (sojutsu var, root of herbaceous,dried orange peel, parsnip). Group two is treated with only gushen changan as comparison. The treatment course for both groups is four weeks.Result: The effectiveness is 87.8% for group one, and 65.3% for group 2. The comparison is based on statistical inference (Plt;0.05). The symptoms of both groups witnessed great improvement after treatment, and the difference has particular meaning (Plt;0.01). The difference between group one and group two after treatment also has statistical meaning.Conclusion: Gushen changan and tongxie yaofang has fairly good clinical effectiveness for diarrhea irritable bowel syndrome.   Key words:nbsp; Diarrhea;nbsp; Colon disease, functional;nbsp; Gushen changan   肠易激综合征(Irritable Bowel Syndrome,IBS)是临床常见的胃肠功能性疾病,是一组包括腹痛、腹胀伴排便习惯改变(腹泻/便秘)以及大便性状异常(稀便、粘液便及便秘)等临床表现的症候群,持续存在或间歇发作,但无器质性疾病(无形态学、细菌学及生化代谢等异常)的证据,常好发于青壮年。近年来,我科用谷参肠安合痛泻要方治疗腹泻型肠易激综合征49例,取得较满意的疗效,现报道如下:   1nbsp; 临床资料   1.1nbsp; 病例选择:西医诊断参照IBS罗马标准Ⅱ的标准(1999年修订)[1],其分型参照《肠易激综合征诊治共识意见》[2],中医辩证参照《中医内科学#12539;泄泻》[3]中有关久泻的分型标准。凡年龄在18~65岁之间,符合西医诊断及其分型和中医辩证标准,受试前经大便常规、血生化、结肠镜或钡剂灌肠造影、腹部B超等检查,未发现有消化道器质性病变患者均纳入本观察。对于年
显示全部
相似文档